Page last updated: 2024-10-21

tacrine and Dizziness

tacrine has been researched along with Dizziness in 1 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.

Research Excerpts

ExcerptRelevanceReference
"The pharmacokinetics of 9-amino-1,2,3,4-tetrahydroacridine; tacrine, THA, was studied after intravenous administration and following the first and last oral doses of a seven week clinical trial involving 8 patients with amyotrophic lateral sclerosis, ALS."3.68Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine. ( Aquilonius, SM; Askmark, H; Hartvig, P; Lindström, B; Wiklund, L, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartvig, P1
Askmark, H1
Aquilonius, SM1
Wiklund, L1
Lindström, B1

Other Studies

1 other study available for tacrine and Dizziness

ArticleYear
Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.
    European journal of clinical pharmacology, 1990, Volume: 38, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aminoacridines; Amyotrophic Lateral Sclerosis; Biological Availab

1990
chemdatabank.com